Paternal thrombophilic gene mutations are not associated with recurrent miscarriage

American Journal of Reproductive Immunology

Volumn 60, Issue 4, 2008, Pages 325-332

  Toth, Bettina ^a   Vocke, Franziska ^a   Rogenhofer, Nina ^a   Friese, Klaus ^a   Thaler, Christian J ^a   Lohse, Peter ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Factor V Leiden; MTHFR 677C>T; Prothrombin 20210G>A; Recurrent miscarriage; Thrombophilia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; EMBRYO DEVELOPMENT; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GERMANY; GESTATIONAL AGE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MUTATIONAL ANALYSIS; PREGNANCY OUTCOME; PREVALENCE; PRIORITY JOURNAL; RECURRENT ABORTION; RISK ASSESSMENT; RISK FACTOR; THROMBOPHILIA;

ABORTION, HABITUAL; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FACTOR V; FATHERS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROTHROMBIN; THROMBOPHILIA;

EID: 51649112961     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2008.00630.x     Document Type: Article

References (47)

1. Carrington B, SacPs G, Regan L: Recurrent miscarriage: pathophysiology and outcome. Curr Opin Obstet Gynecol 2005; 17:591-597.
2. Li TC, Makris M, Tomsu M, Tuckerman E, Laird S: Recurrent miscarriage: aetiology, management and prognosis. Hum Reprod Update 2002; 8:463-481.
3. Pandey MK, Rani R, Agrawal S: An update in recurrent spontaneous abortion. Arch Gynecol Obstet 2005; 272:95-108.
4. Rai R, Regan L: Recurrent miscarriage. Lancet 2006; 368:601-611.
5. Regan L, Rai R: Epidemiology and the medical causes of miscarriage. Baillieres Best Pract Res Clin Obstet Gynaecol 2000; 14:839-854.
6. Buchholz T, Thaler IJ: Inherited thrombophilia: impact on human reproduction. Am J Reprod Immunol 2003; 50: 20-32.
7. Pihusch R, Buchholz T, Lohse P, Rubsamen H, Rogenhofer N, Hasbargen U, et al.: Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester. Am J Reprod Immunol 2001; 46:124-131.
8. Sehirali S, Inal MM, Yildirim Y, Balim Z, Kosova B, Karamizrak T, et al.: Prothrombin G20210A mutation in cases with recurrent miAcarriage: a study of the mediterranean population. Arch Gynecol Obstet 2005; 273:170-173.
9. Finan RR, Tamim H, Ameen G, Sharida HE, Rashid M, Almawi WY: Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population. Am J Hematol 2002; 71:300-305.
10. Foka ZJ, Lambropoulos AF, Saravelos H, Karas GB, Karavida A, Agorastos T, et al.: Factor V leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages. Hum Reprod 2000; 15:458-462.
11. Goodman CS, Coulam CB, Jeyendran RS, Acosta VA, Roussev R: Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss? Am J Reprod Immunol 2006; 56:230-236.
12. Brenner B, Sarig G, Weiner Z, Younis J, Blumenfeld Z, Lanir N: Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thromb Haemost 1999; 82:6-9.
13. D'Uva M, Di Micco P, Strina I, Alviggi C, Iannuzzo M, Ranieri A, et al.: Hyperhomocysteinemia in women with unexplained sterility or recurrent early pregnancy loss from Southern Italy: A preliminary report. Thromb J 2007; 5:10.
14. Grandone E, Margaglione M, Colaizzo D, d'Addedda M, Cappucci G, Vecchione G, et al.: Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost 1997; 77:822-824.
15. Gerhardt A, Scharf RE, Mikat-Drozdzynski B, Krussel JS, Bender HG, Zotz RB: The polymorphism of platelet membrane integrin alpha2beta1 (alpha2807TT) is associated with premature onset of fetal loss. Thromb Haemost 2005; 93:124-129.
16. Glueck CJ, Gogenini S, Munjal J, Tracy T, Pranikoff J, Wang P: Factor V Leiden mutation: A treatable etiology for sporadic and recurrent pregnancy loss. Fertil Steril 2008; 89:410-416.
17. Glueck CJ, Wang P, Bornovali S, Goldenberg N, Sieve L: Polycystic ovary syndrome, the G1691A factor V Leiden mutation, and plasminogen activator inhibitor activity: Associations with recurrent pregnancy loss. Metabolism 2003; 52: 1627-1632.
18. Guan LX, Du XY, Wang JX, Gao L, Wang RL, Li HB, et al.: [Association of genetic polymorphisms in plasminogen activator inhibitor-1 gene and 5,10-methylenetetrahydrofolate reductase gene with recurrent early spontaneous abortion]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2005; 22:330-333.
19. Li XM, Zhang YZ, Xu YX, Jiang S: [Study on the relationship of MTHFR polymorphisms with unexplained recurrent spontaneous abortion]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2004; 21:39-42.
20. Mahjoub T, Mtiraoui N, Tamim H, Hizem S, Finan RR, Nsiri B, et al.: Association between adverse pregnancy outcomes and maternal factor V G1691A (Leiden) and prothrombin G20210A genotypes in women with a history of recurrent idiopathic miscarriages. Am J Hematol 2005; 80:12-19.
21. Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV, et al.: Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med 2000; 343:1015-1018.
22. Mtiraoui N, Borgi L, Hizem S, Nsiri B, Finan RR, Gris JC, et al.: Prevalence of antiphospholipid antibodies, factor V G1691A (Leiden) and prothrombin G20210A mutations in early and late recurrent pregnancy loss. Eur J Obstet Gynecol Reprod Biol 2005; 119:164-170.
23. Murphy RP, Donoghue C, Nallen RJ, D'Mello M, Regan C, Whitehead AS, et al.: Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy. Arterioscler Thromb Vasc Biol 2000; 20:266-270.
24. Nelen WL, Steegers EA, Eskes TK, Blom HJ: Genetic risk factor for unexplained recurrent early pregnancy loss. Lancet 1997; 350:861.
25. Onderoglu L, Baykal C, Al RA, Demirtas E, Deren O, Gurgey A: High frequency of thrombophilic disorders in women with recurrent fetal miscarriage. Clin Exp Obstet Gynecol 2006; 33:50-54.
26. Reznikoff-Etievan MF, Cayol V, Carbonne B, Robert A, Coulet F, Milliez J: Factor V Leiden and G20210A prothrombin mutations are risk factors for very early recurrent miscarriage. BJOG 2001; 108:1251-1254.
27. Ridker PM, Miletich JP, Buring JE, Ariyo AA, Price DT, Manson JE, et al.: Factor V Leiden mutation as a risk factor for recurrent pregnancy loss. Ann Intern Med 1998; 128:1000-1003.
28. Sottilotta G, Oriana V, Latella C, Luise F, Piromalli A, Ramirez F, et al.: Genetic prothrombotic risk factors in women with unexplained pregnancy loss. Thromb Res 2006; 117:681-684.
29. Souza SS, Ferriani RA, Pontes AG, Zago MA, Franco RF: Factor V leiden and factor II G20210A mutations in patients with recurrent abortion. Hum Reprod 1999; 14:2448-2450.
30. Unfried G, Griesmacher A, Weismuller W, Nagele F, Huber JC, Tempfer CB: The C677T polymorphism of the methylenetetrahydrofolate reductase gene and idiopathic recurrent miscarriage. Obstet Gynecol 2002; 99:614-619.
31. Wang XP, Lin QD, Ma ZW, Zhao AM: [C677T and A1298C mutation of the methylenetetrahydrofolate reductase gene in unexplained recurrent spontaneous abortion]. Zhonghua Fu Chan Ke Za Zhi 2004; 39:238-241.
32. Wolf CE, Haubelt H, Pauer HU, Hinney B, Krome-Cesar C, Legler TJ, et al.: Recurrent pregnancy loss and its relation to FV Leiden, FII G20210A and polymorphisms of plasminogen activator and plasminogen activator inhibitor. Pathophysiol Haemost Thromb 2003; 33:134-137.
33. Wramsby ML, Sten-Linder M, Bremme K: Primary habitual abortions are associated with high frequency of factor V Leiden mutation. Fertil Steril 2000; 74:987-991.
34. Younis JS, Brenner B, Ohel G, Tal J, Lanir N, Ben-Ami M: Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy loss. Am J Reprod Immunol 2000; 43:31-35.
35. Zammiti W, Mtiraoui N, Mercier E, Abboud N, Saidi S, Mahjoub T, et al.: Association of factor V gene polymorphisms (Leiden; Cambridge; Hong Kong and HR2 haplotype) with recurrent idiopathic pregnancy loss in Tunisia. A case-control study. Thromb Haemost 2006; 95: 612-617.
36. Chwatko G, Boers GH, Strauss KA, Shih DM, Jakubowski H: Mutations in methylenetetrahydrofolate reductase or cystathionine beta-synthase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and mice. FASEB J 2007; 21:1707-1713.
37. Dizon-Townson DS, Kinney S, Branch DW, Ward K: The factor V Leiden mutation is not a common cause of recurrent miscarriage. J Reprod Immunol 1997; 34:217-223.
38. Jivraj S, Rai R, Underwood J, Regan L: Genetic thrombophilic mutations among couples with recurrent miscarriage. Hum Reprod 2006; 21:1161-1165.
39. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81:19-25.
40. Dizon-Townson DS, Meline L, Nelson LM, Varner M, Ward K: Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol 1997; 177:402-405.
41. Younis JS, Ohel G, Brenner B, Haddad S, Lanir N, Ben-Ami M: The effect of thrombophylaxis on pregnancy outcome in patients with recurrent pregnancy loss associated with factor V Leiden mutation. BJOG 2000; 107:415-419.
42. Alonso A, Soto I, Urgelles MF, Corte JR, Rodriguez MJ, Pinto CR: Acquired and inherited thrombophilia in women with unexplained fetal losses. Am J Obstet Gynecol 2002; 187:1337-1342.
43. Kutteh WH, Park VM, Deitcher SR: Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil Steril 1999; 71:1048-1053.
44. Carp H, Salomon O, Seidman D, Dardik R, Rosenberg N, Inbal A: Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Hum Reprod 2002; 17:1633-1637.
45. Dilley A, Benito C, Hooper WC, Austin H, Miller C, El-Jamil M, et al.: Mutations in the factor V, prothrombin and MTHFR genes are not risk factors for recurrent fetal loss. J Matern Fetal Neonatal Med 2002; 11:176-182.
46. Altintas A, Pasa S, Akdeniz N, Cil T, Yurt M, Ayyildiz O, et al.: Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: Data from the southeast of Turkey. Ann Hematol 2007; 86:727-731.
47. Blom HJ, Shaw GM, den Heijer M, Finnell RH: Neural tube defects and folate: Case far from closed. Nat Rev Neurosci 2006; 7:724-731.